{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T22:39:22Z","timestamp":1792622362132,"version":"4.5.0"},"reference-count":23,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["advancesinanesthesia.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Advances in Anesthesia"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.aan.2026.06.002","type":"journal-article","created":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T03:15:14Z","timestamp":1787022914000},"page":"233-250","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Suzetrigine (JOURNAVX) for Acute Postoperative Pain"],"prefix":"10.1016","volume":"44","author":[{"given":"Kyle","family":"Pribyl","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammed A.","family":"Farooq Anwar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter K.","family":"Yi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin E.","family":"Vorenkamp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.aan.2026.06.002_bib1","series-title":"Drug overdose deaths in the United States, 2003\u20132023. NCHS Data Brief No. 522","author":"Garnett","year":"2024"},{"key":"10.1016\/j.aan.2026.06.002_bib2","series-title":"Drug overdose deaths in the United States, 2023\u20132024. NCHS Data Brief No. 549","author":"Garnett","year":"2026"},{"issue":"3","key":"10.1016\/j.aan.2026.06.002_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr7103a1","article-title":"CDC clinical practice guideline for prescribing opioids for pain\u2014United States, 2022","volume":"71","author":"Dowell","year":"2022","journal-title":"MMWR Recomm Rep (Morb Mortal Wkly Rep)"},{"issue":"6","key":"10.1016\/j.aan.2026.06.002_bib4","doi-asserted-by":"crossref","DOI":"10.1001\/jamasurg.2017.0504","article-title":"New persistent opioid use after minor and major surgical procedures in US adults","volume":"152","author":"Brummett","year":"2017","journal-title":"JAMA Surg"},{"issue":"2","key":"10.1016\/j.aan.2026.06.002_bib5","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.jpain.2015.12.008","volume":"17","author":"Chou","year":"2016","journal-title":"J Pain"},{"issue":"2","key":"10.1016\/j.aan.2026.06.002_bib6","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1097\/ALN.0000000000003428","article-title":"Perioperative use of gabapentinoids for the management of postoperative acute pain: a systematic review and meta-analysis","volume":"133","author":"Verret","year":"2020","journal-title":"Anesthesiology"},{"issue":"2","key":"10.1016\/j.aan.2026.06.002_bib7","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1152\/physrev.00052.2017","article-title":"The role of voltage-gated sodium channels in pain signaling","volume":"99","author":"Bennett","year":"2019","journal-title":"Physiol Rev"},{"issue":"5","key":"10.1016\/j.aan.2026.06.002_bib8","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/s41583-021-00444-w","article-title":"The physiological function of different voltage-gated sodium channels in pain","volume":"22","author":"Goodwin","year":"2021","journal-title":"Nat Rev Neurosci"},{"issue":"47","key":"10.1016\/j.aan.2026.06.002_bib9","doi-asserted-by":"crossref","first-page":"19444","DOI":"10.1073\/pnas.1216080109","article-title":"Gain-of-function Nav1.8 mutations in painful neuropathy","volume":"109","author":"Faber","year":"2012","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.aan.2026.06.002_bib10","series-title":"JOURNAVX (suzetrigine) [package insert]","year":"2025"},{"issue":"17","key":"10.1016\/j.aan.2026.06.002_bib11","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1161\/CIRCULATIONAHA.123.067331","article-title":"Autonomic dysfunction linked to inhibition of the Nav1.7 sodium channel","volume":"149","author":"Regan","year":"2024","journal-title":"Circulation"},{"key":"10.1016\/j.aan.2026.06.002_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2023.108416","article-title":"Understanding the physiological role of NaV1.9: challenges and opportunities for pain modulation","volume":"245","author":"Brackx","year":"2023","journal-title":"Pharmacol Ther"},{"issue":"2","key":"10.1016\/j.aan.2026.06.002_bib13","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1007\/s40122-024-00697-0","article-title":"Pharmacology and mechanism of action of suzetrigine, a potent and selective NaV1.8 pain signal inhibitor for the treatment of moderate to severe pain","volume":"14","author":"Osteen","year":"2025","journal-title":"Pain Ther"},{"issue":"5","key":"10.1016\/j.aan.2026.06.002_bib14","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1056\/NEJMoa2209870","article-title":"Selective inhibition of NaV1.8 with VX-548 for acute pain","volume":"389","author":"Jones","year":"2023","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.aan.2026.06.002_bib15","first-page":"1085","article-title":"Suzetrigine, a nonopioid NaV1.8 inhibitor for treatment of moderate-to-severe acute pain: two phase 3 randomized clinical trials","volume":"142","author":"Bertoch","year":"2025","journal-title":"Anesthesiology"},{"key":"10.1016\/j.aan.2026.06.002_bib17","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.2147\/JPR.S509144","article-title":"Suzetrigine, a non-opioid NaV1.8 inhibitor with broad applicability for moderate-to-severe acute pain: a phase 3 single-arm study for surgical or non-surgical acute pain","volume":"18","author":"McCoun","year":"2025","journal-title":"J Pain Res"},{"key":"10.1016\/j.aan.2026.06.002_bib18","article-title":"Efficacy and safety of suzetrigine for acute postoperative pain: a GRADE assessed systematic review and meta-analysis","author":"Burhan M, Ashraf S, Raza SHA, Javid S, Qadri M","year":"2025","journal-title":"J Pain Palliat Care Pharmacother"},{"issue":"3","key":"10.1016\/j.aan.2026.06.002_bib19","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.bja.2025.06.014","article-title":"Suzetrigine for acute postoperative pain: a systematic review and meta-analysis of current evidence","volume":"135","author":"Amaral","year":"2025","journal-title":"Br J Anaesth"},{"issue":"1","key":"10.1016\/j.aan.2026.06.002_bib20","doi-asserted-by":"crossref","first-page":"82","DOI":"10.4103\/sja.sja_602_25","article-title":"Selective Nav1.8 inhibition by suzetrigine, a novel nonopioid analgesic for acute pain management: a systematic review and metanalysis","volume":"20","author":"Bansal","year":"2026","journal-title":"Saudi J Anaesth"},{"issue":"7","key":"10.1016\/j.aan.2026.06.002_bib21","first-page":"729","article-title":"The effectiveness and value of suzetrigine for moderate to severe acute pain: a summary from the Institute for Clinical and Economic Review\u2019s Midwest Comparative Effectiveness Public Advisory Council","volume":"31","author":"Nikitin","year":"2025","journal-title":"J Manag Care Spec Pharm"},{"key":"10.1016\/j.aan.2026.06.002_bib22","article-title":"Suzetrigine for the treatment of acute pain: comment","author":"Milam","year":"2025","journal-title":"Anesthesiology"},{"key":"10.1016\/j.aan.2026.06.002_bib23","article-title":"Suzetrigine for the treatment of acute pain: comment","author":"Siddiqui","year":"2025","journal-title":"Anesthesiology"},{"issue":"12","key":"10.1016\/j.aan.2026.06.002_bib24","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.3390\/ph18121816","article-title":"Toward brain NaV1.8 imaging with [11C]suzetrigine","volume":"18","author":"Tokala","year":"2025","journal-title":"Pharmaceuticals"}],"container-title":["Advances in Anesthesia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0737614626000109?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0737614626000109?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T22:03:31Z","timestamp":1792620211000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0737614626000109"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["S0737614626000109"],"URL":"https:\/\/doi.org\/10.1016\/j.aan.2026.06.002","relation":{},"ISSN":["0737-6146"],"issn-type":[{"value":"0737-6146","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Suzetrigine (JOURNAVX) for Acute Postoperative Pain","name":"articletitle","label":"Article Title"},{"value":"Advances in Anesthesia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.aan.2026.06.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}